Quia Pharma AB (publ) (STO:QUIA)
Sweden
· Delayed Price · Currency is SEK 0.0076
-0.0008 (-9.52%)
May 14, 2025, 1:00 PM CET
Quia Pharma AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 0.46 | 4.37 | 5.57 | 8.73 | 3.74 | Upgrade
|
| Other Revenue | - | - | - | - | -0 | Upgrade
|
| Revenue | 0.46 | 4.37 | 5.57 | 8.73 | 3.74 | Upgrade
|
| Revenue Growth (YoY) | -89.48% | -21.53% | -36.15% | 133.49% | -16.28% | Upgrade
|
| Cost of Revenue | 0.13 | 2.2 | 2.24 | 8.2 | 6.73 | Upgrade
|
| Gross Profit | 0.33 | 2.17 | 3.33 | 0.53 | -2.99 | Upgrade
|
| Selling, General & Admin | 12.31 | 13.82 | 15.72 | 15.88 | 20.61 | Upgrade
|
| Other Operating Expenses | -2.26 | 0 | 0.05 | 0.02 | 0.07 | Upgrade
|
| Operating Expenses | 14 | 17.68 | 19.13 | 18.1 | 21.95 | Upgrade
|
| Operating Income | -13.67 | -15.51 | -15.79 | -17.57 | -24.93 | Upgrade
|
| Interest Expense | -0.27 | -1.01 | -4.3 | -2.43 | -2.78 | Upgrade
|
| Interest & Investment Income | 0 | 0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -13.93 | -16.52 | -20.09 | -20 | -27.71 | Upgrade
|
| Asset Writedown | -15 | - | - | - | - | Upgrade
|
| Pretax Income | -28.93 | -16.52 | -20.09 | -20 | -27.71 | Upgrade
|
| Net Income | -28.93 | -16.52 | -20.09 | -20 | -27.71 | Upgrade
|
| Net Income to Common | -28.93 | -16.52 | -20.09 | -20 | -27.71 | Upgrade
|
| Shares Outstanding (Basic) | 948 | 74 | 2 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 948 | 74 | 2 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 1173.14% | 4105.13% | 182.75% | 51.66% | 33.80% | Upgrade
|
| EPS (Basic) | -0.03 | -0.22 | -11.34 | -31.92 | -67.07 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.22 | -11.34 | -31.92 | -67.07 | Upgrade
|
| Free Cash Flow | -10.17 | -10.27 | -18.18 | -20.19 | -28.87 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.14 | -10.26 | -32.22 | -69.89 | Upgrade
|
| Gross Margin | 72.17% | 49.63% | 59.81% | 6.04% | -79.94% | Upgrade
|
| Operating Margin | -2970.65% | -354.64% | -283.35% | -201.25% | -666.86% | Upgrade
|
| Profit Margin | -6288.91% | -377.75% | -360.40% | -229.09% | -741.11% | Upgrade
|
| Free Cash Flow Margin | -2211.09% | -234.70% | -326.12% | -231.27% | -772.21% | Upgrade
|
| EBITDA | -9.71 | -13.43 | -13.98 | -16.01 | -23.67 | Upgrade
|
| EBITDA Margin | - | - | -250.79% | -183.37% | - | Upgrade
|
| D&A For EBITDA | 3.95 | 2.08 | 1.82 | 1.56 | 1.27 | Upgrade
|
| EBIT | -13.67 | -15.51 | -15.79 | -17.57 | -24.93 | Upgrade
|
| EBIT Margin | - | - | -283.35% | -201.25% | - | Upgrade
|
| Revenue as Reported | 2.83 | 4.39 | 5.58 | 8.73 | 3.74 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.